Literature DB >> 7506283

Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus.

M Urban1, T Winkler, M P Landini, W Britt, M Mach.   

Abstract

The IgG subclass pattern against linear antibody binding sites on glycoproteins of human cytomegalovirus (HCMV) was investigated in HCMV-positive healthy blood donors, human immunodeficiency virus-infected persons, sera from mothers with primary HCMV infection during pregnancy and their children, and sequential sera from transplant recipients. As antigens, three immunodominant domains capable of inducing neutralizing antibodies during natural infection were selected on glycoproteins gp58/116 (gB) and gp86 (gH). Bacterial fusion proteins representing these regions were used as antigens in a subclass-specific ELISA. Reactivity against the antibody binding site on gp86 was detected in both the IgG1 and IgG3 subclasses. In contrast, exclusively IgG1 antibodies were found against both linear domains on glycoprotein complex gp58/116 and also against full-length gp58/116 expressed in insect cells. The data demonstrate a differential regulation of the antibody response to envelope components of HCMV.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7506283     DOI: 10.1093/infdis/169.1.83

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis.

Authors:  Ekaterina Maidji; Susan McDonagh; Olga Genbacev; Takako Tabata; Lenore Pereira
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

2.  EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function.

Authors:  K Bickham; C Münz; M L Tsang; M Larsson; J F Fonteneau; N Bhardwaj; R Steinman
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays.

Authors:  A E Greijer; J M van de Crommert; S J Stevens; J M Middeldorp
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

4.  Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream.

Authors:  Naoki Nozawa; June Fang-Hoover; Takako Tabata; Ekaterina Maidji; Lenore Pereira
Journal:  J Clin Virol       Date:  2009-10-24       Impact factor: 3.168

5.  Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.

Authors:  Zhongde Wang; Corinna La Rosa; Rebecca Maas; Heang Ly; John Brewer; Shahram Mekhoubad; Pirouz Daftarian; Jeff Longmate; William J Britt; Don J Diamond
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 6.  Maternal Immunity and the Natural History of Congenital Human Cytomegalovirus Infection.

Authors:  William J Britt
Journal:  Viruses       Date:  2018-08-03       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.